Stem cell-based therapies for spinal cord injury

Journal of Spinal Cord Medicine

Volumn 32, Issue 2, 2009, Pages 105-114

  Tewarie, Rishi S Nandoe ^a   Hurtado, Andres ^b   Bartels, Ronald H ^a   Grotenhuis, Andre ^a   Oudega, Martin ^b,c,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Axon regeneration; Cell transplantation; Ethics; Gene therapy; Neuroprotection; Pluripotency; Spinal cord injuries; Stem cells; Totipotency

Indexed keywords

ADULT STEM CELL; CELL DIFFERENTIATION; CELL RENEWAL; CELL TRANSDIFFERENTIATION; EMBRYONIC STEM CELL; ETHICS; HUMAN; MULTIPOTENT STEM CELL; NERVE FIBER REGENERATION; NEUROPROTECTION; PLURIPOTENT STEM CELL; REVIEW; SOCIAL ASPECT; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; TOTIPOTENT STEM CELL; ZYGOTE;

EID: 66449137291     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.2009.11760761     Document Type: Review

References (140)

1. Altman J. Autoradiographic study of degenerative and regenerative proliferation of neuroglia cells with tritiated thymidine. Exp Neurol. 1962;5:302-318.
2. The Boulder Committee. Embryonic vertebrate central nervous system: revised terminology. Anat Rec. 1970;166(2):257-261.
3. Graziadei PP, Monti Graziadei GA. Neurogenesis and neuron regeneration in the olfactory system of mammals. Deafferentation and reinnervation of the olfactory bulb following section of the fila olfactoria in rat. J Neurocytol. 1980;9(2):145-162. (Pubitemid 10098938)
4. Rakic P. Limits of neurogenesis in primates. Science. 1985;227(4690):1054-1056. (Pubitemid 15142049)
5. McKay JS, Blakemore WF, Franklin RJ. The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS. Neuropathol Appl Neurobiol. 1997;23(1):50-58. (Pubitemid 27081217)
6. Eriksson PS, Perfilieva E, Bjork-Eriksson T, et al. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4(11):1313-1317. (Pubitemid 28512114)
7. Snyder EY. Neural transplantation: an approach to cellular plasticity in the developing central nervous system. Review. Semin Perinatol. 1992;16(2):106-121.
8. Fisher LJ, Gage FH. Grafting in the mammalian central nervous system. Physiol Rev. 1993;73(3):583-616. (Pubitemid 23204853)
9. Gage FH. Neuronal stem cells: their characterization and utilization. Neurobiol Aging. 1994;15(suppl 2):S191. (Pubitemid 124001284)
10. Snyder EY, Macklis JD. Multipotent neural progenitor or stem-like cells may be uniquely suited for therapy for some neurodegenerative conditions. Clin Neurosci. 1995;3(5):310-316. (Pubitemid 26372835)
11. Brüstle O, McKay RD. Neuronal progenitors as tools for cell replacement in the nervous system. Curr Opin Neurobiol. 1996;6(5):688-695. (Pubitemid 26387726)
12. Polak JM, Bishop AE. Stem cells and tissue engineering: past, present, and future. Ann N Y Acad Sci. 2006;Apr(1068):352-366. (Pubitemid 43824168)
13. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls, and uncertainties. Lessons for and from the crypt. Development. 1990; 110(4): 1001-1020. (Pubitemid 120009472)
14. Orford KW, Scadden DT. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet. 2008;9(2):115-128.
15. Koenig S, Krause P, Drabent B, et al. The expression of mesenchymal, neural and haematopoietic stem cell markers in adult hepatocytes proliferating in vitro. J Hepatol. 2006;44(6):1115-1124.
16. Yoon J, Min BG, Kim YH, et al. Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model. Acta Cardiol. 2005;60(3):277-284. (Pubitemid 40827236)
17. Murrell W, Féron F, Wetzig A, et al. Multipotent stem cells from adult olfactory mucosa. Dev Dyn. 2005;233(2):496-515. (Pubitemid 40734050)
18. Kruse C, Bodó E, Petschnik AE, Danner S, Tiede S, Paus R. Towards the development of a pragmatic technique for isolating and differentiating nestin-positive cells from human scalp skin into neuronal and glial cell populations: generating neurons from human skin? Exp Dermatol. 2006;15(10):794-800. (Pubitemid 44425730)
19. Chou SH, Kuo TK, Liu M, Lee OK. In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice J Orthop Res. 2006;24(3):301-312. (Pubitemid 43772989)
20. McKenzie IA, Biernaskie J, Toma JG, Midha R, Miller FD. Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J Neurosci. 2006;26(24):6651-6660. (Pubitemid 44318347)
21. Wong CE, Paratore C, Dours-Zimmermann MT, et al. Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin. J Cell Biol. 2006;175(6):1005-1015. (Pubitemid 44969205)
22. Seth S, Narang R, Bhargava B, et al. AIIMS Cardiovascular Stem Cell Study Group. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol. 2006;48(11):2350-2351. (Pubitemid 44855430)
23. Tang Y, Yasuhara T, Hara K, et al. Transplantation of bone marrow-derived stem cells: a promising therapy for stroke. Review. Cell Transplant 2007;16(2):159-169. (Pubitemid 46668790)
24. Johansson CB, Svensson M, Wallstedt L, Janson AM, Frisén J. Neural stem cells in the adult human brain. Exp Cell Res. 1999;253(2):733-736. (Pubitemid 30003135)
25. Pincus DW, Goodman RR, Fraser RA, Nedergaard M, Goldman SA. Neural stem and progenitor cells: a strategy for gene therapy and brain repair. Neurosurgery. 1998;42(4):858-867. (Pubitemid 28208371)
26. Enzmann GU, Benton RL, Talbott JF, Cao Q, Whittemore SR. Functional considerations of stem cell transplantation therapy for spinal cord repair. J Neurotrauma. 2006;23(3-4):479-495. (Pubitemid 43726323)
27. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells. 2007;25(11):2896-2902. (Pubitemid 350127874)
28. Tao H, Ma DD. Evidence for transdifferentiation of human bone marrow-derived stem cells: recent progress and controversies. Pathology. 2003;35(1):6-13. (Pubitemid 36349940)
29. Slack JM. Metaplasia and transdifferentiation: from pure biology to the clinic. Review. Nat Rev Mol Cell Biol. 2007;8(5):369-378. (Pubitemid 46643236)
30. Franklin RJ, Blakemore WF. Requirements for Schwann cell migration within CNS environments: a viewpoint. Review. Int J Dev Neurosci. 1993;11(5):641-649. (Pubitemid 23352352)
31. Takami T, Oudega M, Bates ML, Wood PM, Kleitman N, Bunge MB. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci. 2002;22(15):6670-6681. (Pubitemid 35386423)
32. Filbin MT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci. 2003;4(9):703-713. (Pubitemid 37280150)
33. Gardiner P, Beaumont E, Cormery B. Motoneurones "learn" and "forget" physical activity. Review. Can J Appl Physiol. 2005;30(3):352-370. (Pubitemid 40880714)
34. Martens DJ, Seaberg RM, van der Kooy D. In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord. Eur J Neurosci. 2002;16(6):1045-1057. (Pubitemid 35469163)
35. Mothe AJ, Tator CH. Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat. Neuroscience. 2005;131(1):177-187. (Pubitemid 40170498)
36. Ke Y, Chi L, Xu R, Luo C, Gozal D, Liu R. Early response of endogenous adult neural progenitor cells to acute spinal cord injury in mice. Stem Cells. 2006;24(4):1011-1019. (Pubitemid 44464734)
37. Silver J, Millet JH. Regeneration beyond the glial scar. Nat Rev Neurosci. 2004;5(2):146-156. (Pubitemid 38160289)
38. Galtrey CM, Asher RA, Nothias F, Fawcett JW. Promoting plasticity in the spinal cord with chondroitinase improves functional recovery after peripheral nerve repair. Brain. 2007;130(Pt 4):926-939. (Pubitemid 47355587)
39. Tian DS, Dong Q, Pan DJ, et al. Attenuation of astrogliosis by suppressing of microglial proliferation with the cell cycle inhibitor olomoucine in rat spinal cord injury model. Brain Res. 2007;1154:206-214. (Pubitemid 46856341)
40. Teng YD, Liao WL, Choi H, et al. Physical activity-mediated functional recovery after spinal cord injury: potential roles of neural stem cells. Regen Med. 2006;1(6):763-776.
41. Coutts M, Keirstead HS. Stem cells for the treatment of spinal cord injury. Exp Neurol. 2008;209(2):368-377.
42. Hardy SA, Maltman DJ, Przyborski SA. Mesenchymal stem cells as mediators of neural differentiation. Review. Curr Stem Cell Res Ther. 2008;3(1):43-52.
43. Chen CP, Kiel ME, Sadowski D, McKinnon RD. From stem cells to oligodendrocytes: prospects for brain therapy. Stem Cell Rev. 2007;3(4):280-288.
44. Zietlow R, Lane EL, Dunnett SB, Rosser AE. Human stem cells for CNS repair. Cell Tissue Res. 2008;331(1):301-322. (Pubitemid 350265495)
45. Keirstead HS. Stem cell transplantation into the central nervous system and the control of differentiation. Review. J Neurosci Res. 2001;63(3):233-236. (Pubitemid 32115284)
46. Liu S, Qu Y, Stewart TJ, et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A. 2000;97(11):6126-6131. (Pubitemid 30367534)
47. Billon N, Jolicoeur C, Raff M. Generation and characterization of oligodendrocytes from lineage-selectable embryonic stem cells in vitro. Methods Mol Biol. 2006;330:15-32.
48. Deshpande DM, Kim YS, Martinez T, et al. Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol. 2006;60(1):32-44.
49. Brüstle O. Building brains: neural chimeras in the study of nervous system development and repair. Review. Brain Pathol. 1999;9(3):527-545. (Pubitemid 29316292)
50. McDonald JW, Liu XZ, Qu Y, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med. 1999;5(12):1410-1412.
51. Jendelová P, Herynek V, Urdzíková L, et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res. 2004;76(2):232-243. (Pubitemid 38451211)
52. Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, Rao MS. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol. 2001;172(2):383-397. (Pubitemid 34075087)
53. Li XJ, Du ZW, Zarnowska ED, et al. Specification of motoneurons from human embryonic stem cells. Nat Biotechnol. 2005;23(2):215-221. (Pubitemid 40255332)
54. Lee H, Shamy GA, Elkabetz Y, et al. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells. 2007;25(8):1931-1939. (Pubitemid 47258171)
55. Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci. 2005;25(19):4694-4705. (Pubitemid 40664118)
56. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia. 2005;49(3):385-396. (Pubitemid 40222916)
57. Cao QL, Zhang YP, Howard RM, et al. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol. 2001; 167(1):48-58. (Pubitemid 32066408)
58. Cao QL, Onifer SM, Whittemore SR. Labeling stem cells in vitro for identification of their differentiated phenotypes after grafting into the CNS. Methods Mol Biol. 2002;198:307-318.
59. Setoguchi T, Nakashima K, Takizawa T, et al. Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor. Exp Neurol. 2004:189(1):33-44. (Pubitemid 39024453)
60. Enzmann GU, Benton RL, Woock JP, Howard RM, Tsoulfas P, Whittemore SR. Consequences of noggin expression by neural stem, glial, and neuronal precursor cells engrafted into the injured spinal cord. Exp Neurol. 2005;195(2):293-304. (Pubitemid 41297782)
61. Nunes MC, Roy NS, Keyoung HM, et al. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med. 2003;9(4):439-447. (Pubitemid 36460078)
62. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A. 2005;102(39):14069-14074. (Pubitemid 41377704)
63. Cummings BJ, Uchida N, Tamaki SJ, Anderson AJ. Human neural stem cell differentiation following transplantation into spinal cord injured mice: association with recovery of locomotor function. Neurol Res. 2006;28(5):474-481. (Pubitemid 44141313)
64. Nandoe Tewarie RD, Hurtado A, Levi AD, Grotenhuis JA, Oudega M. Bone marrow stromal cells for repair of the spinal cord: towards clinical application. Cell Transplant. 2006;15(7):563-577. (Pubitemid 44904669)
65. Parr AM, Kulbatski I, Tator CH. Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury. J Neurotrauma. 2007;24(5):835-845. (Pubitemid 46799275)
66. Castro RF, Jackson KA, Goodell MA, Robertson CS, Liu H, Shine HD. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science. 2002;297(5585):1299.
67. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147. (Pubitemid 29282067)
68. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science. 1999;284(5417):1168-1170. (Pubitemid 29288406)
69. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve. 1995;18(12):1417-1426.
70. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1995;279(5256):1528-1530.
71. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann Acad Sci. 2001;Jun(938):221-229. (Pubitemid 32620035)
72. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999;103(5):697-705. (Pubitemid 29122423)
73. Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. PNAS. 1998;95(7):3908-3913. (Pubitemid 28173227)
74. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science. 2000;290(5497):1775- 1779. (Pubitemid 32004810)
75. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science. 2000;290(5497):1779-11180 (Pubitemid 32004811)
76. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000;164(2):247-256. (Pubitemid 32008970)
77. Kohyama J, Abe H, Shimazaki T, et al. Brain from bone: Efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation. 2001;68(4-5):235-244. (Pubitemid 33754996)
78. Saito T, Kuang JQ, Lin CC, Chiu RC. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J Thorac Cardiovasc Surg. 2003;126(1):114-123. (Pubitemid 36909948)
79. Eisenberg CA, Burch JB, Eisenberg LM. Bone marrow cells transdifferentiate to cardiomyocytes when introduced into the embryonic heart. Stem Cells. 2006;24(5):1236-1245. (Pubitemid 44464692)
80. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5(3):309-313. (Pubitemid 29124367)
81. Chamberlain JR, Schwarze U, Wang PR, et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science. 2004;303(5661):1198- 1201. (Pubitemid 38233586)
82. Olsson F, Denham M, Cole TJ, Hooper SB, Mollard R. Deriving respiratory cell types from stem cells. Curr Stem Cell Res Ther. 2007;2(3):197-208. (Pubitemid 47499939)
83. Masaka T, Miyazaki M, Du G, et al. Derivation of hepatopancreatic intermediate progenitor cells from a clonal mesenchymal stem cell line of rat bone marrow origin. Int J Mol Med. 2008;22(4):447-452.
84. Sakai D, Mochida J, Yamamoto Y, et al. Transplantation of mesenchymal stem cells embedded in Atelocollagen gel to the intervertebral disc: a potential therapeutic model for disc degeneration. Biomaterials. 2003;24(20):3531-3541. (Pubitemid 36703127)
85. Sakai D, Mochida J, Iwashina T, et al. Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials. 2006;27(3):335-345. (Pubitemid 41457236)
86. Sakai D, Mochida J, Iwashina T, et al. Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine. 2005;30(21):2379-2387. (Pubitemid 41567599)
87. Helm GA, Gazit Z. Future uses of mesenchymal stem cells in spine surgery. Neurosurg Focus. Review. 2005;19(6):E13.
88. Lee J, Kuroda S, Shichinohe H, et al. Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology. 2003;23(3):169-180. (Pubitemid 37210130)
89. Sugaya K. Possible use of autologous stem cell therapies for Alzheimer's disease. Curr Alzheimer Res. 2005;2(3):367-376. (Pubitemid 40980195)
90. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57(6):874-882. (Pubitemid 40798626)
91. Lladó J, Haenggeli C, Maragakis NJ, Snyder EY, Rothstein JD. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci. 2004;27(3):322-331. (Pubitemid 39433844)
92. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol. 2003;181(2):115-129. (Pubitemid 36629234)
93. Hofstetter CP, Schwarz EJ, Hess D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002;99(4):2199-2204. (Pubitemid 34169038)
94. Ohta M, Suzuki Y, Noda T, et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol. 2004;187(2):266-278. (Pubitemid 38610273)
95. Labouyrie E, Dubus P, Groppi A, et al. Expression of neurotrophins and their receptors in human bone marrow. Am J Pathol. 1999;154(2):405-415. (Pubitemid 29094091)
96. García R, Aguiar J, Alberti E, de la Cuétara K, Pavón N. Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors. Biochem Biophys Res Commun. 2004;316(3):753-754. (Pubitemid 38368017)
97. Mahmood A, Lu D, Chopp M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma. 2004;21(1):33-39. (Pubitemid 38141800)
98. Ye M, Chen S, Wang X, et al. Glial cell line-derived neurotrophic factor in bone marrow stromal cells of rat. Neuroreport. 2005;16(6):581-584. (Pubitemid 40586087)
99. Pfeifer K, Vroemen M, Blesch A, Weidner N. Adult neural progenitor cells provide a permissive guiding substrate for corticospinal axon growth following spinal cord injury. Eur J Neurosci. 2004;20(7):1695-1704. (Pubitemid 39471562)
100. Raisman G, Li Y. Repair of neural pathways by olfactory ensheathing cells. Nat Rev Neurosci. 2007;8(4):312-319. (Pubitemid 46452322)
101. Ramon-Cueto A. Olfactory ensheathing glia transplantation into the injured spinal cord. Prog Brain Res. 2000;128:265-272. (Pubitemid 35461243)
102. Mathews DJ, Sugarman J, Bok H, et al. Cell-based interventions for neurologic conditions. Ethical challenges for early human trials. Neurology. 2008;71(4):288-293.
103. Baptiste DC, Fehlings MG. Update on the treatment of spinal cord injury. Prog Brain Res. 2007;161:217-233. (Pubitemid 47017406)
104. Sell S. Stem Cells Handbook. Totowa, NJ: Humana Press; 2004.
105. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A. 1993;90(18):8424-8428. (Pubitemid 23277681)
106. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145-1147. (Pubitemid 28516247)
107. Bakken AM. Cryopreserving human peripheral blood progenitor cells. Review. Curr Stem Cell Res Ther. 2006;1(1):47-54.
108. Ballen KK, Haley NR, Kurtzberg J, et al. Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank. Transfusion. 2006;46(12):2063-2070. (Pubitemid 44813723)
109. Cibelli JB, Grant KA, Chapman KB, et al. Parthenogenetic stem cells in nonhuman primates. Science. 2002;295(5556):819. (Pubitemid 34118355)
110. Vrana KE, Hipp JD, Goss AM, et al. Nonhuman primate parthenogenetic stem cells. Proc Natl Acad Sci U S A. 2003;100(suppl 1):11911-11916. (Pubitemid 37205903)
111. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008;132(4):661-680.
112. Park YB, Kim YY, Oh SK, et al. Alterations of proliferative and differentiation potentials of human embryonic stem cells during long-term culture. Exp Mol Med. 2008;40(1):98-108.
113. Ray S, Atkuri KR, Deb-Basu D, et al. MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species. Cancer Res. 2006;66(13):6598-6605. (Pubitemid 44085615)
114. Nussbaum J, Minami E, Laflamme MA, et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 2007;21(7):1345-1357. (Pubitemid 46684837)
115. Shiras A, Chettiar ST, Shepal V, Rajendran G, Prasad GR, Shastry P. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Stem Cells. 2007;25(6):1478-1489.
116. Zeng X, Rao MS. Human embryonic stem cells: long term stability, absence of senescence and a potential cell source for neural replacement. Neuroscience. 2007;145(4):1348-1358. (Pubitemid 46602730)
117. Lois C, Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A. 1993;90(5):2074-2077. (Pubitemid 23070000)
118. Uchida N, Buck DW, He D, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A. 2000;97(26):14720-14725. (Pubitemid 32016642)
119. Mayer-Proschel M, Kalyani AJ, Mujtaba T, Rao MS. Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron. 1997;19(4):773-785. (Pubitemid 27471383)
120. Doetsch F, Caillé I, Lim DA, García-Verdugo JM, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999;97(6):703-716. (Pubitemid 29278045)
121. Wright LS, Prowse KR, Wallace K, Linskens MH, Svendsen CN. Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro. Exp Cell Res. 2006;312(11):2107-2120. (Pubitemid 43850935)
122. Gorin NC, Piantadosi S, Stull M, Bonte H, Wingard JR, Civin C. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood. J Hematother Stem Cell Res. 2002;11(2):277-292. (Pubitemid 34309521)
123. Vats A, Bielby RC, Tolley NS, Nerem R, Polak JM. Review. Stem cells. Lancet. 2005;366(9485):592-602. (Pubitemid 41149084)
124. Foroni C, Galli R, Cipelletti B, et al. Resilience to transformation and inherent genetic and functional stability of adult neural stem cells ex vivo. Cancer Res. 2007;67(8):3725-3733. (Pubitemid 46762158)
125. Goldenring JM. The brain-life theory: towards a consistent biological definition of humanness. J Med Ethics. 1985;11(4):198-204.
126. Peterfy A. Fetal viability as a threshold to personhood. A legal analysis. J Leg Med. 1995;16(4):607-636. (Pubitemid 26024464)
127. Robertson JA. Ethics and policy in embryonic stem cell research. Kennedy Inst Ethics J. 1999;9(2):109-136.
128. Roman Catholic Church. Catechism of the Catholic Church. 2nd English translation. Vatican City: Libreria Editrice Vaticana; 1994.
129. Westpal SP. The next IVF revolution? New Scientist. 2003;178(2394):4-5.
130. Hübner K, Fuhrmann G, Christenson LK, et al. Derivation of oocytes from mouse embryonic stem cells. Science. 2003;300(5623):1251-1256. (Pubitemid 36618231)
131. Newson AJ, Smajdor AC. Artificial gametes: new paths to parenthood? J Med Ethics. 2005;31(3):184-186. (Pubitemid 40378695)
132. Whittaker P. Stem cells to gametes: how far should we go? Hum Fertil Camb. 2007;10(1):1-5. (Pubitemid 46470343)
133. Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Review. Nat Rev Mol Cell Biol. 2008;9(9):725-729.
134. Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451(7175):141-146.
135. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;25;126(4):663-676. (Pubitemid 44233629)
136. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448(7151):313-317. (Pubitemid 47080336)
137. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-1920.
138. Yu J, Thomson JA. Pluripotent stem cell lines. Genes Dev. 2008;22(15):1987-1997.
139. Blelloch R, Venere M, Yen J, Ramalho-Santos M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell. 2007;1(3):245-247. (Pubitemid 47355331)
140. Lowry WE, Richter L, Yachechko R, et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A. 2008;105(8):2883-2888.